Multiple Ras-dependent Phosphorylation Pathways Regulate Myc Protein Stability

Overview

Journal Genes Dev

Specialty Molecular Biology

Date 2000 Oct 6

PMID 11018017

Citations 654

Authors

R Sears

F Nuckolls

E Haura

Y Taya

K Tamai

J R Nevins

Affiliations

Soon will be listed here.

Abstract

Our recent work has shown that activation of the Ras/Raf/ERK pathway extends the half-life of the Myc protein and thus enhances the accumulation of Myc activity. We have extended these observations by investigating two N-terminal phosphorylation sites in Myc, Thr 58 and Ser 62, which are known to be regulated by mitogen stimulation. We now show that the phosphorylation of these two residues is critical for determining the stability of Myc. Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK. Conversely, phosphorylation of Thr 58, likely mediated by GSK-3 but dependent on the prior phosphorylation of Ser 62, is associated with degradation of Myc. Further analysis demonstrates that the Ras-dependent PI-3K pathway is also critical for controlling Myc protein accumulation, likely through the control of GSK-3 activity. These observations thus define a synergistic role for multiple Ras-mediated phosphorylation pathways in the control of Myc protein accumulation during the initial stage of cell proliferation.

Citing Articles

Phosphoproteomics identifies determinants of PAK inhibitor sensitivity in leukaemia cells.

Casado P, Marfa S, Hadi M, Gerdes H, Martin-Guerrero S, Miraki-Moud F Cell Commun Signal. 2025; 23(1):135.

PMID: 40082888 PMC: 11907924. DOI: 10.1186/s12964-025-02107-0.

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Jiang Z, Allkanjari M, Chung P, Tran H, Ghanbari-Azarnier R, Wang D Cancers (Basel). 2025; 17(5).

PMID: 40075567 PMC: 11898778. DOI: 10.3390/cancers17050720.

Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 Rearrangements.

Tiwari A, Paithane U, Friedlein J, Tashiro K, Saulnier O, Barbosa K bioRxiv. 2025; .

PMID: 40027648 PMC: 11870553. DOI: 10.1101/2025.02.17.638454.

Regulating MYC translation in cancer.

Hussain Z, Sherman M Nat Cell Biol. 2025; 27(3):379-381.

PMID: 39920278 DOI: 10.1038/s41556-024-01589-3.

Screening Methods to Discover the FDA-Approved Cancer Drug Encorafenib as Optimally Selective for Metallothionein Gene Loss Ovarian Cancer.

Rees A, Villamor E, Evans D, Gooz M, Fallon C, Mina-Abouda M Genes (Basel). 2025; 16(1.

PMID: 39858588 PMC: 11764637. DOI: 10.3390/genes16010042.

References

Boyle W, van der Geer P, Hunter T . Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 1991; 201:110-49. DOI: 10.1016/0076-6879(91)01013-r. View

Lamarche N, Tapon N, Stowers L, Burbelo P, Aspenstrom P, BRIDGES T . Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell. 1996; 87(3):519-29. DOI: 10.1016/s0092-8674(00)81371-9. View

Seth A, Gonzalez F, Gupta S, Raden D, Davis R . Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem. 1992; 267(34):24796-804. View

Charron J, Malynn B, Fisher P, Stewart V, Jeannotte L, Goff S . Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 1992; 6(12A):2248-57. DOI: 10.1101/gad.6.12a.2248. View

Davis A, Wims M, Spotts G, Hann S, Bradley A . A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 1993; 7(4):671-82. DOI: 10.1101/gad.7.4.671. View

Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I . Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet. 1993; 5(1):56-61. DOI: 10.1038/ng0993-56. View

Henriksson M, Bakardjiev A, Klein G, Luscher B . Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene. 1993; 8(12):3199-209. View

Pulverer B, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett J . Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene. 1994; 9(1):59-70. View

Clark H, Yano T, Otsuki T, Jaffe E, Shibata D, Raffeld M . Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res. 1994; 54(13):3383-6. View

10.

Lutterbach B, Hann S . Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol. 1994; 14(8):5510-22. PMC: 359071. DOI: 10.1128/mcb.14.8.5510-5522.1994. View

11.

van der Geer P, Hunter T . Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates. Electrophoresis. 1994; 15(3-4):544-54. DOI: 10.1002/elps.1150150173. View

12.

White M, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M . Multiple Ras functions can contribute to mammalian cell transformation. Cell. 1995; 80(4):533-41. DOI: 10.1016/0092-8674(95)90507-3. View

13.

He X, Woodgett J, Varmus H, Dawid I . Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature. 1995; 374(6523):617-22. DOI: 10.1038/374617a0. View

14.

Fenteany G, Standaert R, Lane W, Choi S, Corey E, Schreiber S . Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 1995; 268(5211):726-31. DOI: 10.1126/science.7732382. View

15.

Coso O, Chiariello M, Yu J, Teramoto H, Crespo P, Xu N . The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 1995; 81(7):1137-46. DOI: 10.1016/s0092-8674(05)80018-2. View

16.

Minden A, Lin A, Claret F, Abo A, Karin M . Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 1995; 81(7):1147-57. DOI: 10.1016/s0092-8674(05)80019-4. View

17.

Seger R, KREBS E . The MAPK signaling cascade. FASEB J. 1995; 9(9):726-35. View

18.

DeGregori J, Kowalik T, Nevins J . Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol. 1995; 15(8):4215-24. PMC: 230660. DOI: 10.1128/MCB.15.8.4215. View

19.

Dudley D, Pang L, Decker S, Bridges A, Saltiel A . A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995; 92(17):7686-9. PMC: 41210. DOI: 10.1073/pnas.92.17.7686. View

20.

Dominguez I, Itoh K, Sokol S . Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc Natl Acad Sci U S A. 1995; 92(18):8498-502. PMC: 41184. DOI: 10.1073/pnas.92.18.8498. View